![]() |
|
|
Vol. 285, Issue 1, 170-177, April 1998
Binding
Sites in the Rat and Human Stomach
Institute of Pharmacology and Toxicology (G.J.M., K.D., M.B.,
M.G.), University of Bonn, Bonn, Germany,
Byk Gulden Lomberg GmbH
(W.A.S.), Konstanz, Germany and
Evangelisches Krankenhaus (D.W.S.),
Bonn, Germany
Radioligand binding experiments were carried out to identify and
characterize nonadrenoceptor [3H]idazoxan binding sites
and [3H](1,2-di-(2-tolyl)guanidine) binding sites in the
rat and human stomach. Furthermore, we examined two selected aspects of
their potential functional significance. Binding of
[3H]idazoxan (Kd = 11.1 nM and
12.4 nM, respectively) and [3H]DTG
(Kd = 932 nM and 242 nM, respectively) to cell
membranes from rat and human stomach was rapid, reversible, specific
and saturable. In rat stomach, binding of the radioligands was
inhibited by imidazolines and by nonimidazoline
-site ligands,
respectively, at different rank orders of affinity, which suggests the
existence of I2-imidazoline binding sites as well as
2-sites. In two functional models, the direct effects of
I2-site ligands and
2-site ligands on
gastric smooth muscle and glands were investigated. (1) Cirazoline, clonidine and 4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline (BDF
6143) failed to contract the longitudinal muscle of the rat stomach
fundus; BDF 6143 also failed to induce relaxation of this preparation
when it was precontracted with 30 mM KCl. (2) Clonidine, idazoxan, BDF
6143, 1,2-di-(2-tolyl)guanidine, agmatine and
(R)-3-(3-hydroxyphenyl)-N-propylpiperidine up to 100 µM did not
induce acid secretion from rabbit isolated gastric glands. Our data
provide evidence that the rat stomach is endowed with
2
sites and I2 binding sites in addition to the previously
identified non-I1/non-I2
[3H]clonidine binding sites. Our experiments also offer
basic evidence of the existence of I2 and
binding sites
in the human stomach. Neither the I2 and
[3H]clonidine binding sites nor the
sites in rat
stomach are directly related to a postsynaptic effect on gastric smooth
muscle or to acid release from isolated gastric glands.